Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Proto Labs (PRLB) Common Equity (2016 - 2025)

Proto Labs (PRLB) has disclosed Common Equity for 15 consecutive years, with $673.9 million as the latest value for Q4 2025.

  • Quarterly Common Equity rose 0.56% to $673.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $673.9 million through Dec 2025, up 0.56% year-over-year, with the annual reading at $673.9 million for FY2025, 0.56% up from the prior year.
  • Common Equity hit $673.9 million in Q4 2025 for Proto Labs, up from $664.7 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $832.0 million in Q1 2022 to a low of $656.8 million in Q1 2025.
  • Historically, Common Equity has averaged $729.4 million across 5 years, with a median of $686.3 million in 2024.
  • Biggest five-year swings in Common Equity: skyrocketed 38.4% in 2021 and later decreased 17.9% in 2023.
  • Year by year, Common Equity stood at $828.5 million in 2021, then fell by 15.79% to $697.6 million in 2022, then decreased by 0.34% to $695.3 million in 2023, then dropped by 3.62% to $670.2 million in 2024, then rose by 0.56% to $673.9 million in 2025.
  • Business Quant data shows Common Equity for PRLB at $673.9 million in Q4 2025, $664.7 million in Q3 2025, and $664.7 million in Q2 2025.